Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids.

Brackenridge, A L, Jackson, N, Jefferson, W, Stolinski, M, Shojaee-Moradie, F, Hovorka, R, Umpleby, A M and Russell-Jones, D (2009) Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids. Diabetic Medicine, 26(5), pp. 532-539. ISSN (print) 0742-3071

Full text not available from this archive.

Abstract

In patients with Type 2 diabetes and normal lipids, treatment with rosiglitazone or pioglitazone had no significant effect on lipoprotein metabolism compared with placebo.

Item Type: Article
Research Area: Allied health professions and studies
Other laboratory based clinical subjects
Faculty, School or Research Centre: Faculty of Science, Engineering and Computing
Faculty of Science, Engineering and Computing > School of Life Sciences
Depositing User: Michael Stolinski
Date Deposited: 26 Jul 2012 11:01
Last Modified: 17 Dec 2012 12:08
URI: http://eprints.kingston.ac.uk/id/eprint/23251

Actions (Repository Editors)

Item Control Page Item Control Page